Johnson Financial Group, Inc. Corcept Therapeutics Inc Transaction History
Johnson Financial Group, Inc.
- $2.2 Billion
- Q2 2025
Shares
1 transactions
Others Institutions Holding CORT
# of Institutions
481Shares Held
83.4MCall Options Held
489KPut Options Held
1.02M-
Black Rock Inc. New York, NY16.5MShares$1.23 Billion0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.68MShares$718 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY7.72MShares$573 Million20.11% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.27MShares$465 Million0.65% of portfolio
-
Parallel Advisors, LLC3.87MShares$287 Million5.83% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $7.94B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...